New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry
Agilex Biolabs Partners with Endpoints News for Webinar on Rapid Vaccine Development in Australia
ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to
Azelis publishes its 2020 sustainability report
SINGAPORE- Azelis, a leading innovative service provider in the specialty chemicals and food ingredients industry, is proud to publish its
Catalent Plans Multi-Phase, $100 Million Expansion of Italian Facility to Increase Biologics Manufacturing Capabilities in Europe
SOMERSET, N.J. — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,
FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Endometrial Carcinoma
Immunotherapy and Tyrosine Kinase Inhibitor Combination Approved for the Treatment of Patients With Advanced Endometrial Carcinoma Study Results Demonstrated Statistically
CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation
On 9 November 2021, the 18th Annual CPhI Pharma Awards will take place in Milan, Italy at the Stella Polare Convention